Data completeness
0/8 — Limited
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GEOPEN (carbenicillin disodium) is an injectable antibiotic in the penicillin class used to treat bacterial infections, particularly gram-negative and some gram-positive pathogens. As a broad-spectrum beta-lactam antibiotic, it works by inhibiting bacterial cell wall synthesis. It is administered via injection for systemic infections where oral therapy is inadequate.
Pre-Launch
As a pre-launch product, commercial infrastructure is still being built; limited current team size with aggressive hiring expected post-approval.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
GEOPEN represents a career entry point in Pfizer's infectious disease franchise during a critical pre-launch phase. Success on this program will depend on navigating a competitive injectable antibiotic market and building market access in hospital systems.
Brand ManagerMedical Science Liaison
Worked on GEOPEN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.